Eligibility Requirements

Income Limit
Up to 400% of Federal Poverty Level for free medication through Amgen Safety Net Foundation
Insurance Requirements
Free medication for uninsured patients. Copay card for commercially insured patients.

Covered Medications

The following medications are covered by Enbrel Support (via Amgen):

Enbrel

How to Apply

Application Steps
  1. Speak with your healthcare provider about Enbrel Support (via Amgen). Your doctor, nurse, or social worker can help determine if you qualify.
  2. Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
  3. Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
  4. Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Apply at Enbrel Support (via Amgen) →

Check If You Qualify

Use our free Assistance Finder tool to check eligibility for Enbrel Support (via Amgen) and other programs that may help reduce your medication costs.

Open Assistance Finder
Compare Prices
Find the cheapest pharmacy for Enbrel
Compare pharmacy prices near you on RxGrab
Natural Alternatives
Supplement alternatives for Enbrel
Explore evidence-based options on Health Britannica

Frequently Asked Questions

How can I get free Enbrel?

Uninsured patients who meet income requirements (up to 400% FPL) can receive free Enbrel through the Amgen Safety Net Foundation. Apply through your rheumatologist or dermatologist.

Is there an Enbrel copay card?

Yes, Amgen offers the Enbrel Support copay card for commercially insured patients, which can significantly reduce monthly out-of-pocket costs.

Are Enbrel biosimilars available?

Yes, Enbrel biosimilars (such as Erelzi and Hadlima) are available. These may offer lower costs. Ask your doctor and insurance plan about biosimilar options.

Get Prescription Savings Alerts

Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.